{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:58:45Z","timestamp":1791874725133,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The WHO classifications of 2017 and 2022 recommend the use of pituitary transcription factors PIT-1, T-PIT and SF-1 as well as GATA3 and ER\u03b1 for histopathological diagnosis. The aim of this study is to demonstrate their diagnostic impact in a large retrospective cohort. 921 PitNETs\/PAs diagnosed in our department between October 2004 and April 2018 were retrospectively reassessed according to the WHO classifications 2017 and 2022. The original classification (WHO 2004) and the clinical data were retrieved from the patient records. Hormone-immunonegative null cell adenomas represented the largest subgroup (397 of 921) in the WHO 2004 classification. Of these, 377 were reclassified as gonadotroph PitNETs\/PAs, and 14 were assigned to a non-gonadotroph hormone-producing cell line. Only 6 cases remained null cell tumors. 27 of 35 plurihormonal adenomas were assigned to a specific cell line in the 2017 and 2022 WHO classifications. Of 489 adenomas formerly classified as expressing of 1 or 2 hormones, the histopathological diagnosis was confirmed in 459 cases with the use of TP. Of the remaining 30 cases, 12 cases with positive immunostaining of 2 hormones could be assigned to a single cell line, and 18 cases changed their lineage. The correct correlation with clinical data significantly improved from 75.4% (WHO 2004) to 96.2% (WHO 2017 and 2022). Corticotroph PitNETs showed the highest risk for recurrence (21.9%) and progression (55.8%). The new classification enables more accurate (sub)classification and significantly improves clinicopathological correlation. In individual cases, it is essential to consider the reclassification to predict the clinical prognosis and to schedule the follow-up accordingly.<\/jats:p>","DOI":"10.1186\/s40478-025-02050-8","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T02:53:49Z","timestamp":1751079229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transcription factor-based classification of pituitary adenomas \/ PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-4958","authenticated-orcid":false,"given":"Isabella","family":"Nasi-Kordhishti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Hladik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosmas","family":"Kandilaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-1276","authenticated-orcid":false,"given":"Felix","family":"Behling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-8077","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-6209","authenticated-orcid":false,"given":"Jens","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"1","key":"2050_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/ENDO:28:1:027","volume":"28","author":"G Kontogeorgos","year":"2005","unstructured":"Kontogeorgos G (2005) Classification and pathology of pituitary tumors. Endocrine 28(1):27\u201335. https:\/\/doi.org\/10.1385\/ENDO:28:1:027","journal-title":"Endocrine"},{"issue":"1","key":"2050_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-005-1093-6","volume":"111","author":"M Al-Shraim","year":"2006","unstructured":"Al-Shraim M, Asa SL (2006) The 2004 world health organization classification of pituitary tumors: what is new? Acta Neuropathol 111(1):1\u20137. https:\/\/doi.org\/10.1007\/s00401-005-1093-6","journal-title":"Acta Neuropathol"},{"key":"2050_CR3","volume-title":"World health organization classification of tumours: tumours of endocrine organs","author":"R DeLellis","year":"2004","unstructured":"DeLellis R, Lloyd R, Heitz P, Eng C (2004) World health organization classification of tumours: tumours of endocrine organs. IARC, Lyons, France"},{"issue":"5","key":"2050_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1210\/jcem.77.5.8077321","volume":"77","author":"SL Asa","year":"1993","unstructured":"Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP (1993) Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77(5):1275\u20131280. https:\/\/doi.org\/10.1210\/jcem.77.5.8077321","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1146\/annurev.ph.52.030190.004013","volume":"52","author":"HA Ingraham","year":"1990","unstructured":"Ingraham HA, Albert VR, Chen RP, Crenshaw EB 3d, Elsholtz HP, He X et al (1990) A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol 52:773\u2013791. https:\/\/doi.org\/10.1146\/annurev.ph.52.030190.004013","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"2050_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(88)90038-4","volume":"55","author":"HA Ingraham","year":"1988","unstructured":"Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR et al (1988) A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55(3):519\u2013529. https:\/\/doi.org\/10.1016\/0092-8674(88)90038-4","journal-title":"Cell"},{"issue":"6","key":"2050_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0092-8674(01)00282-3","volume":"104","author":"B Lamolet","year":"2001","unstructured":"Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A et al (2001) A pituitary cell-restricted T box factor, tpit, activates POMC transcription in Cooperation with Pitx homeoproteins. Cell 104(6):849\u2013859. https:\/\/doi.org\/10.1016\/s0092-8674(01)00282-3","journal-title":"Cell"},{"issue":"4","key":"2050_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-017-1768-9","volume":"134","author":"E Sjostedt","year":"2017","unstructured":"Sjostedt E, Bollerslev J, Mulder J, Lindskog C, Ponten F, Casar-Borota O (2017) A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours. Acta Neuropathol 134(4):675\u2013677. https:\/\/doi.org\/10.1007\/s00401-017-1768-9","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2050_CR9","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1210\/jcem.81.6.8964846","volume":"81","author":"SL Asa","year":"1996","unstructured":"Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S (1996) The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81(6):2165\u20132170. https:\/\/doi.org\/10.1210\/jcem.81.6.8964846","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2050_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1242\/dev.128.2.147","volume":"128","author":"L Zhao","year":"2001","unstructured":"Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA et al (2001) Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 128(2):147\u2013154. https:\/\/doi.org\/10.1242\/dev.128.2.147","journal-title":"Development"},{"issue":"2","key":"2050_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10014-018-0314-3","volume":"35","author":"N Inoshita","year":"2018","unstructured":"Inoshita N, Nishioka H (2018) The 2017 WHO classification of pituitary adenoma: overview and comments. Brain Tumor Pathol 35(2):51\u201356. https:\/\/doi.org\/10.1007\/s10014-018-0314-3","journal-title":"Brain Tumor Pathol"},{"issue":"4","key":"2050_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535. https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2050_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243. https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Endocr Pathol"},{"key":"2050_CR14","first-page":"11","volume-title":"WHO classification of tumours of endocrine glands","author":"R Osamura","year":"2017","unstructured":"Osamura R, Lopes M, Grossman A, Kontogeorgos G (2017) WHO classification of tumours of the pituitary. In: Lloyd R, Osamura R, Kl\u00f6ppel R (eds) WHO classification of tumours of endocrine glands. IARC, Lyon, France, pp 11\u201363"},{"issue":"1","key":"2050_CR15","doi-asserted-by":"publisher","first-page":"e220079","DOI":"10.1530\/EO-22-0079","volume":"3","author":"NF Lenders","year":"2023","unstructured":"Lenders NF, Earls PE, Inder WJ, McCormack AI (2023) The evolution in pituitary tumour classification: a clinical perspective. Endocr Oncol 3(1):e220079. https:\/\/doi.org\/10.1530\/EO-22-0079","journal-title":"Endocr Oncol"},{"issue":"3","key":"2050_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00292-021-00932-x","volume":"42","author":"W Saeger","year":"2021","unstructured":"Saeger W (2021) [The 2017 WHO classification of pituitary tumors]. Pathologe 42(3):333\u2013351. https:\/\/doi.org\/10.1007\/s00292-021-00932-x","journal-title":"Pathologe"},{"issue":"4","key":"2050_CR17","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology club proposal. Endocr Relat Cancer 24(4):C5\u2013C8. https:\/\/doi.org\/10.1530\/ERC-17-0004","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2050_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33(1):6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"2050_CR19","unstructured":"SankeyMATIC https:\/\/sankeymatic.com\/build\/"},{"issue":"3 Suppl","key":"2050_CR20","first-page":"1041","volume":"52","author":"B Balinisteanu","year":"2011","unstructured":"Balinisteanu B, Ceausu RA, Cimpean AM, Baciu I, Baculescu N, Coculescu M et al (2011) Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases. Rom J Morphol Embryol 52(3 Suppl):1041\u20131045. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22119822","journal-title":"Rom J Morphol Embryol"},{"issue":"2","key":"2050_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","volume":"21","author":"E Manojlovic-Gacic","year":"2018","unstructured":"Manojlovic-Gacic E, Engstrom BE, Casar-Borota O (2018) Histopathological classification of non-functioning pituitary neuroendocrine tumors. Pituitary 21(2):119\u2013129. https:\/\/doi.org\/10.1007\/s11102-017-0855-1","journal-title":"Pituitary"},{"issue":"4","key":"2050_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355. https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"issue":"2","key":"2050_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156(2):203\u2013216. https:\/\/doi.org\/10.1530\/eje.1.02326","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2050_CR24","doi-asserted-by":"publisher","first-page":"e12870","DOI":"10.1111\/nan.12870","volume":"49","author":"M Dottermusch","year":"2023","unstructured":"Dottermusch M, Schuller U, Hagel C, Saeger W (2023) Unveiling the identities of null cell tumours: epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour\/adenoma classification. Neuropathol Appl Neurobiol 49(1):e12870. https:\/\/doi.org\/10.1111\/nan.12870","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2050_CR25","doi-asserted-by":"publisher","unstructured":"Torregrosa-Quesada ME, Garcia-Martinez A, Silva-Ortega S, Martinez-Lopez S, Camara R, Fajardo C et al (2019) How valuable is the RT-qPCR of pituitary-Specific transcription factors for identifying pituitary neuroendocrine tumor subtypes according to the new WHO 2017 criteria?? Cancers (Basel) 11(12). https:\/\/doi.org\/10.3390\/cancers11121990","DOI":"10.3390\/cancers11121990"},{"issue":"7","key":"2050_CR26","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","volume":"23","author":"WL Bi","year":"2017","unstructured":"Bi WL, Horowitz P, Greenwald NF, Abedalthagafi M, Agarwalla PK, Gibson WJ et al (2017) Landscape of genomic alterations in pituitary adenomas. Clin Cancer Res 23(7):1841\u20131851. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0790","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2050_CR27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/neuonc\/noab044","volume":"23","author":"MS Mosella","year":"2021","unstructured":"Mosella MS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP et al (2021) DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro Oncol 23(8):1292\u20131303. https:\/\/doi.org\/10.1093\/neuonc\/noab044","journal-title":"Neuro Oncol"},{"issue":"2","key":"2050_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12022-016-9418-7","volume":"27","author":"W Saeger","year":"2016","unstructured":"Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schofl C, Petersenn S et al (2016) Clinical impact of the current WHO classification of pituitary adenomas. Endocr Pathol 27(2):104\u2013114. https:\/\/doi.org\/10.1007\/s12022-016-9418-7","journal-title":"Endocr Pathol"},{"key":"2050_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","volume":"107","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O (2021) Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 107:87\u201395. https:\/\/doi.org\/10.1016\/j.humpath.2020.10.004","journal-title":"Hum Pathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02050-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T02:53:51Z","timestamp":1751079231000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02050-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02050-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the ethics committee of the Eberhard-Karls-University T\u00fcbingen (registration no. 263\/2018BO2). All procedures were performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from the patients in order to evaluate and publish the data anonymously. All authors approved the final version and publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}